{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:28:32Z","timestamp":1761290912387,"version":"3.37.0"},"reference-count":153,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,10,23]],"date-time":"2008-10-23T00:00:00Z","timestamp":1224720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold>Chronic hepatitis C (CHC), a curable infection, remains endemic worldwide. More than 90% of individuals with haemophilia have been infected with hepatitis C virus (HCV) mostly caused by transfusion with non\u2010virucidally treated clotting factor concentrates. Relevant to haemophilics, the risk of cirrhosis with CHC infection is greatest in males, those who have been infected for a long time, consume alcohol regularly, and\/or are co\u2010infected with HIV. The cure rate, using the current standard therapy for CHC with pegylated\u2010interferon\u2010\u03b1 given weekly and ribavirin daily, ranges from 43% to 65% in those infected with genotype 1 and 50\u201390% with genotype 2 and 3 infections. Eradication of hepatitis C in those co\u2010infected with HIV is less in part because full dose therapy is poorly tolerated. Achieving a sustained virological response (SVR) prevents progression to cirrhosis and in those with established cirrhosis prevents liver failure, and reduces the risk if hepatocellular carcinoma, and the need for liver transplant. Novel treatment options now in development are predominantly focused on inhibitors of HCV\u2010specific enzymes. The treatment paradigm for haemophilics infected with hepatitis C is that all should be assessed for treatment once a diagnosis of chronic hepatitis C is made in order to achieve the highest chance of an SVR, i.e. cure.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2008.01917.x","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T08:55:39Z","timestamp":1232009739000},"page":"20-32","source":"Crossref","is-referenced-by-count":6,"title":["When to treat and the benefits of treating hepatitis C in patients with haemophilia"],"prefix":"10.1111","volume":"15","author":[{"given":"H.","family":"PATEL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. J.","family":"HEATHCOTE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,15]]},"reference":[{"key":"e_1_2_12_2_2","first-page":"35","article-title":"Report of WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Belgium","volume":"6","author":"Global Surveillance and control of hepatitis C","year":"1999","journal-title":"J Viral Hepatol"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(02)00078-8"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.07.031"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410802"},{"volume-title":"A Study to Characterize the Epidemiology of Hepatitis C in Canada, 2002","year":"2004","author":"Remis R","key":"e_1_2_12_6_2"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.1.254.254"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.6.845"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91124-S"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.2.412.412"},{"key":"e_1_2_12_11_2","unstructured":"World Federation of Haemophilia.2006 WFH Global Survey 2006.http:\/\/www.wfh.org\/index.asp?lang=EN."},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4407"},{"key":"e_1_2_12_13_2","unstructured":"Centers for Disease Control and Prevention.Report on the Universal Data Collection Program.2004:1\u201333."},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.02343.x"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08312.x"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01808.x"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210243"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649923"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80249-3"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01415.x"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80379-1"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80377-8"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50019"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00668-1"},{"key":"e_1_2_12_25_2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff LB","year":"2002","journal-title":"Hepatology"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212313272702"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904223401602"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909163411202"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.8169"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.21905"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120409"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00556.x"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38050.593634.63"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.02.002"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9024300"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-7-40"},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21492"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-10-200711200-00003"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280238"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.069"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07642-8"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)00097-0"},{"key":"e_1_2_12_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.11.009"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280632"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00340.x"},{"key":"e_1_2_12_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr075652"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300319"},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032502"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401001"},{"key":"e_1_2_12_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05555.x"},{"key":"e_1_2_12_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21511"},{"key":"e_1_2_12_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280330"},{"key":"e_1_2_12_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270637"},{"key":"e_1_2_12_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00407-6"},{"key":"e_1_2_12_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/155.4.323"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20127"},{"key":"e_1_2_12_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02407.x"},{"key":"e_1_2_12_58_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24432"},{"key":"e_1_2_12_59_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36370"},{"key":"e_1_2_12_60_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.018770"},{"key":"e_1_2_12_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04308.x"},{"key":"e_1_2_12_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199602000-00006"},{"key":"e_1_2_12_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.2.288"},{"key":"e_1_2_12_64_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50267"},{"key":"e_1_2_12_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2003.11.004"},{"key":"e_1_2_12_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11427"},{"key":"e_1_2_12_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00456-2"},{"key":"e_1_2_12_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.09.022"},{"key":"e_1_2_12_69_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.12.049"},{"key":"e_1_2_12_70_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-8-200010170-00009"},{"key":"e_1_2_12_71_2","doi-asserted-by":"crossref","unstructured":"VeldtBJ ChenW HeathcoteEJet\u00a0al.Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.Hepatology2008;47:1856\u201362.","DOI":"10.1002\/hep.22251"},{"key":"e_1_2_12_72_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.08.032"},{"key":"e_1_2_12_73_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.027581"},{"key":"e_1_2_12_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300409"},{"key":"e_1_2_12_75_2","first-page":"1584","article-title":"End\u2010stage liver disease in persons with hemophilia and transfusion\u2010associated infections","volume":"100","author":"Goedert JJ","year":"2002","journal-title":"Blood"},{"key":"e_1_2_12_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05413-5"},{"key":"e_1_2_12_77_2","first-page":"602","article-title":"Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study","volume":"6","author":"Eyster ME","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_12_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21757"},{"key":"e_1_2_12_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14844-1"},{"key":"e_1_2_12_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2004.04.003"},{"key":"e_1_2_12_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80198-0"},{"key":"e_1_2_12_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.0.CO;2-H"},{"key":"e_1_2_12_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907013410104"},{"key":"e_1_2_12_84_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.11.4068-4071.2002"},{"key":"e_1_2_12_85_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.1.126"},{"key":"e_1_2_12_86_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i20.2963"},{"key":"e_1_2_12_87_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20733"},{"key":"e_1_2_12_88_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20119"},{"key":"e_1_2_12_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_2_12_90_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_2_12_91_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00010"},{"key":"e_1_2_12_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00211-8"},{"key":"e_1_2_12_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22319"},{"key":"e_1_2_12_94_2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2004.02.007","article-title":"Peginterferon alfa\u20102b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3","volume":"40","author":"Zeuzem S","year":"2004","journal-title":"J Hepatol"},{"key":"e_1_2_12_95_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066403"},{"key":"e_1_2_12_96_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20467"},{"key":"e_1_2_12_97_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00889.x"},{"key":"e_1_2_12_98_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21712"},{"key":"e_1_2_12_99_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50364"},{"key":"e_1_2_12_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(08)60009-4"},{"key":"e_1_2_12_101_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22061"},{"key":"e_1_2_12_102_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.07.022"},{"key":"e_1_2_12_103_2","first-page":"1367","article-title":"High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C","volume":"91","author":"Mancuso ME","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_12_104_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02619.x"},{"key":"e_1_2_12_105_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1155\/2006\/638272","article-title":"Predictors of antiviral therapy in a post\u2010transfusion cohort of hepatitis C patients","volume":"20","author":"Witkos M","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"e_1_2_12_106_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01083.x"},{"key":"e_1_2_12_107_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20263"},{"key":"e_1_2_12_108_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01322.x"},{"key":"e_1_2_12_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01548.x"},{"key":"e_1_2_12_110_2","first-page":"2563","article-title":"Immunosuppression may lead to progression of hepatitis C virus\u2010associated liver disease in hemophiliacs coinfected with HIV","volume":"91","author":"Rockstroh JK","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_12_111_2","doi-asserted-by":"publisher","DOI":"10.1086\/319273"},{"key":"e_1_2_12_112_2","doi-asserted-by":"publisher","DOI":"10.1086\/517808"},{"key":"e_1_2_12_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80334-6"},{"key":"e_1_2_12_114_2","doi-asserted-by":"publisher","DOI":"10.1086\/517808"},{"key":"e_1_2_12_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2007.05.014"},{"key":"e_1_2_12_116_2","doi-asserted-by":"publisher","DOI":"10.1086\/367643"},{"key":"e_1_2_12_117_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200109070-00021"},{"key":"e_1_2_12_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.03.003"},{"key":"e_1_2_12_119_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1155\/2007\/631054","article-title":"Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals","volume":"18","author":"C\u00f4t\u00e9 P","year":"2007","journal-title":"Can J Inf Dis Med Micro"},{"key":"e_1_2_12_120_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2006.00749.x"},{"key":"e_1_2_12_121_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200303280-00028"},{"key":"e_1_2_12_122_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.49.32833"},{"key":"e_1_2_12_123_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-3-199908030-00003"},{"key":"e_1_2_12_124_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33023"},{"key":"e_1_2_12_125_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20073"},{"key":"e_1_2_12_126_2","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/138245"},{"key":"e_1_2_12_127_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.050"},{"key":"e_1_2_12_128_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01489.x"},{"key":"e_1_2_12_129_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20482"},{"key":"e_1_2_12_130_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.027"},{"key":"e_1_2_12_131_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00870.x"},{"key":"e_1_2_12_132_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000142583.00102.45"},{"key":"e_1_2_12_133_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073255"},{"key":"e_1_2_12_134_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.131607"},{"key":"e_1_2_12_135_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03316.x"},{"key":"e_1_2_12_136_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001610-200407000-00002"},{"key":"e_1_2_12_137_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1155\/2007\/652365","article-title":"The role of hepatology nurse in the difficult\u2010to\u2010treat hepatitis C population","volume":"21","author":"Ford JA","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"e_1_2_12_138_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000145538.43865.72"},{"key":"e_1_2_12_139_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35950"},{"key":"e_1_2_12_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.12.031"},{"key":"e_1_2_12_141_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-832934"},{"key":"e_1_2_12_142_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-864783"},{"key":"e_1_2_12_143_2","first-page":"705A","article-title":"HCV RNA results from a phase II, randomized, open\u2010label study of omega interferon (IFN) with or without ribavirin in IFN\u2010na\u00a8\u0131ve genotype 1 chronic HCV patients","volume":"42","author":"Gorbakov VV","year":"2005","journal-title":"Hepatology"},{"key":"e_1_2_12_144_2","first-page":"278A","article-title":"A phase 2 study of albuferon in combination with ribavirin in non\u2010responders to prior interferon therapy for chronic hepatitis C","volume":"42","author":"Nelson D","year":"2005","journal-title":"Hepatology"},{"key":"e_1_2_12_145_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.037002"},{"key":"e_1_2_12_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)81503-X"},{"key":"e_1_2_12_147_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.02.037"},{"key":"e_1_2_12_148_2","article-title":"Interim analysis results from a phase 2 study of telaprevir with peginterferon Alfa\u20102a and ribavirin in treatment\u2010na\u00efve subjects with Hepatitis C","volume":"47","author":"Jacobson IM","year":"2007","journal-title":"Hepatology"},{"key":"e_1_2_12_149_2","article-title":"PROVE2: Phase II study of Vx950 (Telaprevir) in combination with peginterferon Alfa2a with or without ribavirin in subjects with chronic hepatitis C, first interim analysis","volume":"47","author":"Hezode C","year":"2007","journal-title":"Hepatology"},{"key":"e_1_2_12_150_2","article-title":"Robust synergistic antiviral effect of R1626 in combination with peginterferon Alfa\u20102a (40kd), with or without ribavirin \u2013 interim analysis results of phase 2a study","volume":"47","author":"Pockros PJ","year":"2007","journal-title":"Analysis Hepatology"},{"key":"e_1_2_12_151_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50242"},{"key":"e_1_2_12_152_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300333"},{"key":"e_1_2_12_153_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2007.0064"},{"key":"e_1_2_12_154_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.058"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2008.01917.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2008.01917.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T23:58:47Z","timestamp":1738886327000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2008.01917.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1365-2516.2008.01917.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01917.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"type":"print","value":"1351-8216"},{"type":"electronic","value":"1365-2516"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}